At the time of admission, only lymphopenia, typical of severe COVID-19 (41, 42), as well as a weak T-cell response to ex vivo stimulation were apparent in both CHIP-positive and -negative patients, while there were no differences related to the immune response between the two groups. This evidence concerns the gene STUB1 and lymphopenia.